Sheila Prachand
- Molecular Biology
- Oncology
- Cardiology and Cardiovascular Medicine
- Pathology and Forensic Medicine
- Complementary and alternative medicine top 10%
- Co-authors
- Leo I. GordonAndrew M. EvensRonald B. GartenhausSavita BhallaAmareshwar T.K. SinghKevin A. DavidSathyamangla V. Naga PrasadRichard A. Miller
- Topics
- Retinoids in leukemia and cellular processes (4 papers)Histone Deacetylase Inhibitors Research (4 papers)Andrographolide Research and Applications (3 papers)
- Partner nations
- United StatesPhilippinesCanada
In The Last Decade
Sheila Prachand
20 papers receiving 568 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 328
- Oncology 184
- Cardiology and Cardiovascular Medicine 101
- Pathology and Forensic Medicine 72
- Complementary and alternative medicine 63
Countries citing papers authored by Sheila Prachand
This map shows the geographic impact of Sheila Prachand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Prachand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Prachand more than expected).
Fields of papers citing papers by Sheila Prachand
This network shows the impact of papers produced by Sheila Prachand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Prachand. The network helps show where Sheila Prachand may publish in the future.
Co-authorship network of co-authors of Sheila Prachand
This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Prachand. A scholar is included among the top collaborators of Sheila Prachand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Prachand. Sheila Prachand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 1 | |
| 3 | 34 | |
| 4 | 82 | |
| 5 | Motexafin gadolinium enhances p53-Mdm2 interactions, reducing p53 and downstream targets in lymphoma cell lines. | 2 |
| 6 | 82 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 2 | |
| 11 | 146 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | 43 | |
| 17 | 71 | |
| 18 | Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: enhancement of apoptosis by manipulation of cellular redox state. | 68 |
| 19 | 9 | |
| 20 | 1 |
About Sheila Prachand
Sheila Prachand is a scholar working on Toxicology, Complementary and alternative medicine and Molecular Biology, having authored 20 papers that have together received 572 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Andrographolide Research and Applications (3 papers). The work is most often cited by research in Complementary and alternative medicine (63 citations), Oncology (184 citations) and Toxicology (17 citations). Sheila Prachand has collaborated with scholars based in United States, Philippines and Canada. Frequent co-authors include Leo I. Gordon, Andrew M. Evens, Ronald B. Gartenhaus, Savita Bhalla, Amareshwar T.K. Singh, Kevin A. David, Sathyamangla V. Naga Prasad, Richard A. Miller, Michael A. Burke and Tejaswitha Jairaj Naik. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.